KaloBios Pharmaceuticals CEO Cameron Durrant's 2020 pay jumps 210% to $2.4M
KaloBios Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
KaloBios Pharmaceuticals reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, four executives at KaloBios Pharmaceuticals received on average a compensation package of $1.6M, a 107% increase compared to previous year.
Average pay of disclosed executives at KaloBios Pharmaceuticals
Cameron Durrant, Chief Executive Officer, received $2.4M in total, which increased by 210% compared to 2019. 69% of Durrant's compensation, or $1.7M, was in non-equity incentive plan. Durrant also received $160K in option awards and $600K in salary.
Timothy Morris, Chief Operating and Financial Officer, received a compensation package of $1.5M. 78% of the compensation package, or $1.2M, was in option awards.
David Tousley, Secretary, earned $1.3M in 2020.
Dale Chappell, Chief Scientific Officer, received $1.3M in 2020.
Related executives
You may also like
Source: SEC filing on April 23, 2021.